nodes	percent_of_prediction	percent_of_DWPC	metapath
Misoprostol—PTGER4—Prostaglandin Synthesis and Regulation—ANXA3—ovarian cancer	0.033	0.17	CbGpPWpGaD
Misoprostol—PTGER2—Prostaglandin Synthesis and Regulation—ANXA3—ovarian cancer	0.0271	0.139	CbGpPWpGaD
Misoprostol—PTGER3—Prostaglandin Synthesis and Regulation—ANXA3—ovarian cancer	0.025	0.129	CbGpPWpGaD
Misoprostol—PTGER2—myometrium—ovarian cancer	0.0232	0.0687	CbGeAlD
Misoprostol—PTGER3—myometrium—ovarian cancer	0.0193	0.0571	CbGeAlD
Misoprostol—PTGER2—uterine cervix—ovarian cancer	0.018	0.0534	CbGeAlD
Misoprostol—PTGER4—epithelium—ovarian cancer	0.0178	0.0529	CbGeAlD
Misoprostol—PTGER2—decidua—ovarian cancer	0.0172	0.0509	CbGeAlD
Misoprostol—PTGER2—Ovarian Infertility Genes—NR5A1—ovarian cancer	0.0171	0.0876	CbGpPWpGaD
Misoprostol—PTGER4—decidua—ovarian cancer	0.0169	0.05	CbGeAlD
Misoprostol—PTGER2—Ovarian Infertility Genes—INHA—ovarian cancer	0.0166	0.0852	CbGpPWpGaD
Misoprostol—PTGER2—endometrium—ovarian cancer	0.0163	0.0483	CbGeAlD
Misoprostol—PTGER4—endometrium—ovarian cancer	0.016	0.0474	CbGeAlD
Misoprostol—PTGER2—uterus—ovarian cancer	0.015	0.0445	CbGeAlD
Misoprostol—PTGER4—uterus—ovarian cancer	0.0147	0.0437	CbGeAlD
Misoprostol—PTGER2—female reproductive system—ovarian cancer	0.0135	0.04	CbGeAlD
Misoprostol—PTGER4—female reproductive system—ovarian cancer	0.0133	0.0393	CbGeAlD
Misoprostol—PTGER2—bone marrow—ovarian cancer	0.0128	0.0378	CbGeAlD
Misoprostol—PTGER3—uterus—ovarian cancer	0.0125	0.037	CbGeAlD
Misoprostol—PTGER2—female gonad—ovarian cancer	0.0123	0.0364	CbGeAlD
Misoprostol—PTGER2—vagina—ovarian cancer	0.0122	0.0362	CbGeAlD
Misoprostol—PTGER4—female gonad—ovarian cancer	0.0121	0.0358	CbGeAlD
Misoprostol—PTGER3—female reproductive system—ovarian cancer	0.0112	0.0333	CbGeAlD
Misoprostol—PTGER2—testis—ovarian cancer	0.0109	0.0323	CbGeAlD
Misoprostol—PTGER4—testis—ovarian cancer	0.0107	0.0317	CbGeAlD
Misoprostol—PTGER3—female gonad—ovarian cancer	0.0102	0.0303	CbGeAlD
Misoprostol—PTGER3—testis—ovarian cancer	0.00906	0.0269	CbGeAlD
Misoprostol—PTGER2—Ovarian Infertility Genes—MLH1—ovarian cancer	0.00896	0.046	CbGpPWpGaD
Misoprostol—PTGER2—Ovarian Infertility Genes—PGR—ovarian cancer	0.00849	0.0436	CbGpPWpGaD
Misoprostol—PTGER2—lymph node—ovarian cancer	0.0079	0.0234	CbGeAlD
Misoprostol—PTGER4—lymph node—ovarian cancer	0.00776	0.023	CbGeAlD
Misoprostol—PTGER2—Ovarian Infertility Genes—CCND2—ovarian cancer	0.00679	0.0349	CbGpPWpGaD
Misoprostol—PTGER3—lymph node—ovarian cancer	0.00657	0.0195	CbGeAlD
Misoprostol—PTGER2—Ovarian Infertility Genes—CDKN1B—ovarian cancer	0.00308	0.0158	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—HSD17B6—ovarian cancer	0.00128	0.00656	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—DLC1—ovarian cancer	0.00109	0.00558	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—HSD17B6—ovarian cancer	0.00105	0.00539	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HSD17B6—ovarian cancer	0.000967	0.00497	CbGpPWpGaD
Misoprostol—Dyspnoea—Vinorelbine—ovarian cancer	0.000898	0.00192	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—DLC1—ovarian cancer	0.000891	0.00458	CbGpPWpGaD
Misoprostol—Tinnitus—Paclitaxel—ovarian cancer	0.000889	0.0019	CcSEcCtD
Misoprostol—Acute coronary syndrome—Docetaxel—ovarian cancer	0.000887	0.0019	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—BCL9—ovarian cancer	0.000885	0.00455	CbGpPWpGaD
Misoprostol—Myocardial infarction—Docetaxel—ovarian cancer	0.000882	0.00189	CcSEcCtD
Misoprostol—Neuropathy peripheral—Docetaxel—ovarian cancer	0.000882	0.00189	CcSEcCtD
Misoprostol—Vascular purpura—Epirubicin—ovarian cancer	0.000881	0.00188	CcSEcCtD
Misoprostol—Abnormal vision—Doxorubicin—ovarian cancer	0.000876	0.00187	CcSEcCtD
Misoprostol—Conjunctivitis—Docetaxel—ovarian cancer	0.000875	0.00187	CcSEcCtD
Misoprostol—Fatigue—Vinorelbine—ovarian cancer	0.000868	0.00185	CcSEcCtD
Misoprostol—Hypersensitivity—Topotecan—ovarian cancer	0.000867	0.00185	CcSEcCtD
Misoprostol—Pain—Vinorelbine—ovarian cancer	0.000861	0.00184	CcSEcCtD
Misoprostol—Constipation—Vinorelbine—ovarian cancer	0.000861	0.00184	CcSEcCtD
Misoprostol—Immune system disorder—Paclitaxel—ovarian cancer	0.000861	0.00184	CcSEcCtD
Misoprostol—Chills—Paclitaxel—ovarian cancer	0.000855	0.00183	CcSEcCtD
Misoprostol—Arrhythmia—Paclitaxel—ovarian cancer	0.000852	0.00182	CcSEcCtD
Misoprostol—Hypersensitivity—Melphalan—ovarian cancer	0.000849	0.00181	CcSEcCtD
Misoprostol—Epistaxis—Docetaxel—ovarian cancer	0.000849	0.00181	CcSEcCtD
Misoprostol—Phlebitis—Doxorubicin—ovarian cancer	0.000846	0.00181	CcSEcCtD
Misoprostol—Asthenia—Topotecan—ovarian cancer	0.000845	0.0018	CcSEcCtD
Misoprostol—Alopecia—Paclitaxel—ovarian cancer	0.000842	0.0018	CcSEcCtD
Misoprostol—Vomiting—Chlorambucil—ovarian cancer	0.000841	0.0018	CcSEcCtD
Misoprostol—Blood alkaline phosphatase increased—Doxorubicin—ovarian cancer	0.000838	0.00179	CcSEcCtD
Misoprostol—Feeling abnormal—Vinorelbine—ovarian cancer	0.00083	0.00177	CcSEcCtD
Misoprostol—Asthenia—Melphalan—ovarian cancer	0.000827	0.00177	CcSEcCtD
Misoprostol—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000823	0.00176	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—DLC1—ovarian cancer	0.000822	0.00423	CbGpPWpGaD
Misoprostol—Flatulence—Paclitaxel—ovarian cancer	0.000818	0.00175	CcSEcCtD
Misoprostol—Purpura—Epirubicin—ovarian cancer	0.000817	0.00175	CcSEcCtD
Misoprostol—Vascular purpura—Doxorubicin—ovarian cancer	0.000815	0.00174	CcSEcCtD
Misoprostol—Diarrhoea—Topotecan—ovarian cancer	0.000805	0.00172	CcSEcCtD
Misoprostol—Back pain—Paclitaxel—ovarian cancer	0.000803	0.00172	CcSEcCtD
Misoprostol—Muscle spasms—Paclitaxel—ovarian cancer	0.000798	0.0017	CcSEcCtD
Misoprostol—Abdominal pain—Vinorelbine—ovarian cancer	0.000796	0.0017	CcSEcCtD
Misoprostol—Body temperature increased—Vinorelbine—ovarian cancer	0.000796	0.0017	CcSEcCtD
Misoprostol—Diarrhoea—Melphalan—ovarian cancer	0.000789	0.00169	CcSEcCtD
Misoprostol—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.000788	0.00168	CcSEcCtD
Misoprostol—Nausea—Chlorambucil—ovarian cancer	0.000785	0.00168	CcSEcCtD
Misoprostol—Visual impairment—Docetaxel—ovarian cancer	0.000779	0.00166	CcSEcCtD
Misoprostol—Dizziness—Topotecan—ovarian cancer	0.000778	0.00166	CcSEcCtD
Misoprostol—Anaemia—Paclitaxel—ovarian cancer	0.000767	0.00164	CcSEcCtD
Misoprostol—Purpura—Doxorubicin—ovarian cancer	0.000756	0.00162	CcSEcCtD
Misoprostol—Vomiting—Topotecan—ovarian cancer	0.000748	0.0016	CcSEcCtD
Misoprostol—Syncope—Paclitaxel—ovarian cancer	0.000744	0.00159	CcSEcCtD
Misoprostol—Rash—Topotecan—ovarian cancer	0.000742	0.00159	CcSEcCtD
Misoprostol—Hypersensitivity—Vinorelbine—ovarian cancer	0.000742	0.00159	CcSEcCtD
Misoprostol—Dermatitis—Topotecan—ovarian cancer	0.000742	0.00158	CcSEcCtD
Misoprostol—Headache—Topotecan—ovarian cancer	0.000737	0.00158	CcSEcCtD
Misoprostol—Vomiting—Melphalan—ovarian cancer	0.000733	0.00157	CcSEcCtD
Misoprostol—Dehydration—Epirubicin—ovarian cancer	0.000733	0.00157	CcSEcCtD
Misoprostol—Immune system disorder—Docetaxel—ovarian cancer	0.00073	0.00156	CcSEcCtD
Misoprostol—Loss of consciousness—Paclitaxel—ovarian cancer	0.000729	0.00156	CcSEcCtD
Misoprostol—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.000729	0.00156	CcSEcCtD
Misoprostol—Rash—Melphalan—ovarian cancer	0.000727	0.00155	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—BCL9—ovarian cancer	0.000726	0.00373	CbGpPWpGaD
Misoprostol—Dermatitis—Melphalan—ovarian cancer	0.000726	0.00155	CcSEcCtD
Misoprostol—Chills—Docetaxel—ovarian cancer	0.000725	0.00155	CcSEcCtD
Misoprostol—Asthenia—Vinorelbine—ovarian cancer	0.000723	0.00154	CcSEcCtD
Misoprostol—Arrhythmia—Docetaxel—ovarian cancer	0.000722	0.00154	CcSEcCtD
Misoprostol—Hypertension—Paclitaxel—ovarian cancer	0.000717	0.00153	CcSEcCtD
Misoprostol—Alopecia—Docetaxel—ovarian cancer	0.000714	0.00153	CcSEcCtD
Misoprostol—Breast disorder—Epirubicin—ovarian cancer	0.000712	0.00152	CcSEcCtD
Misoprostol—Myalgia—Paclitaxel—ovarian cancer	0.000707	0.00151	CcSEcCtD
Misoprostol—Arthralgia—Paclitaxel—ovarian cancer	0.000707	0.00151	CcSEcCtD
Misoprostol—Chest pain—Paclitaxel—ovarian cancer	0.000707	0.00151	CcSEcCtD
Misoprostol—Anxiety—Paclitaxel—ovarian cancer	0.000704	0.0015	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—DOK1—ovarian cancer	0.000699	0.00359	CbGpPWpGaD
Misoprostol—Nausea—Topotecan—ovarian cancer	0.000699	0.00149	CcSEcCtD
Misoprostol—Diarrhoea—Vinorelbine—ovarian cancer	0.000689	0.00147	CcSEcCtD
Misoprostol—Nausea—Melphalan—ovarian cancer	0.000685	0.00146	CcSEcCtD
Misoprostol—Confusional state—Paclitaxel—ovarian cancer	0.000683	0.00146	CcSEcCtD
Misoprostol—Dysphagia—Epirubicin—ovarian cancer	0.000681	0.00145	CcSEcCtD
Misoprostol—Back pain—Docetaxel—ovarian cancer	0.00068	0.00145	CcSEcCtD
Misoprostol—Dehydration—Doxorubicin—ovarian cancer	0.000678	0.00145	CcSEcCtD
Misoprostol—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000677	0.00145	CcSEcCtD
Misoprostol—Oedema—Paclitaxel—ovarian cancer	0.000677	0.00145	CcSEcCtD
Misoprostol—Muscle spasms—Docetaxel—ovarian cancer	0.000676	0.00145	CcSEcCtD
Misoprostol—Infection—Paclitaxel—ovarian cancer	0.000673	0.00144	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—BCL9—ovarian cancer	0.00067	0.00344	CbGpPWpGaD
Misoprostol—Shock—Paclitaxel—ovarian cancer	0.000666	0.00142	CcSEcCtD
Misoprostol—Dizziness—Vinorelbine—ovarian cancer	0.000666	0.00142	CcSEcCtD
Misoprostol—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000663	0.00142	CcSEcCtD
Misoprostol—Breast disorder—Doxorubicin—ovarian cancer	0.000659	0.00141	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—PPP1CC—ovarian cancer	0.000657	0.00338	CbGpPWpGaD
Misoprostol—Bronchitis—Epirubicin—ovarian cancer	0.000655	0.0014	CcSEcCtD
Misoprostol—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000655	0.0014	CcSEcCtD
Misoprostol—Anaemia—Docetaxel—ovarian cancer	0.00065	0.00139	CcSEcCtD
Misoprostol—Vomiting—Vinorelbine—ovarian cancer	0.00064	0.00137	CcSEcCtD
Misoprostol—Dysuria—Epirubicin—ovarian cancer	0.000637	0.00136	CcSEcCtD
Misoprostol—Rash—Vinorelbine—ovarian cancer	0.000635	0.00136	CcSEcCtD
Misoprostol—Dermatitis—Vinorelbine—ovarian cancer	0.000634	0.00136	CcSEcCtD
Misoprostol—Hypotension—Paclitaxel—ovarian cancer	0.000633	0.00135	CcSEcCtD
Misoprostol—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000633	0.00135	CcSEcCtD
Misoprostol—Headache—Vinorelbine—ovarian cancer	0.000631	0.00135	CcSEcCtD
Misoprostol—Syncope—Docetaxel—ovarian cancer	0.000631	0.00135	CcSEcCtD
Misoprostol—Dysphagia—Doxorubicin—ovarian cancer	0.00063	0.00135	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	0.00062	0.00319	CbGpPWpGaD
Misoprostol—Loss of consciousness—Docetaxel—ovarian cancer	0.000618	0.00132	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000617	0.00132	CcSEcCtD
Misoprostol—Pneumonia—Epirubicin—ovarian cancer	0.000611	0.0013	CcSEcCtD
Misoprostol—Hypertension—Docetaxel—ovarian cancer	0.000607	0.0013	CcSEcCtD
Misoprostol—Drowsiness—Epirubicin—ovarian cancer	0.000607	0.0013	CcSEcCtD
Misoprostol—Bronchitis—Doxorubicin—ovarian cancer	0.000606	0.00129	CcSEcCtD
Misoprostol—Dyspnoea—Paclitaxel—ovarian cancer	0.000604	0.00129	CcSEcCtD
Misoprostol—Somnolence—Paclitaxel—ovarian cancer	0.000602	0.00129	CcSEcCtD
Misoprostol—Chest pain—Docetaxel—ovarian cancer	0.000599	0.00128	CcSEcCtD
Misoprostol—Myalgia—Docetaxel—ovarian cancer	0.000599	0.00128	CcSEcCtD
Misoprostol—Arthralgia—Docetaxel—ovarian cancer	0.000599	0.00128	CcSEcCtD
Misoprostol—Nausea—Vinorelbine—ovarian cancer	0.000598	0.00128	CcSEcCtD
Misoprostol—Dyspepsia—Paclitaxel—ovarian cancer	0.000596	0.00127	CcSEcCtD
Misoprostol—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000595	0.00127	CcSEcCtD
Misoprostol—PTGER3—G alpha (i) signalling events—CXCL8—ovarian cancer	0.000591	0.00304	CbGpPWpGaD
Misoprostol—Urinary tract infection—Epirubicin—ovarian cancer	0.00059	0.00126	CcSEcCtD
Misoprostol—Conjunctivitis—Epirubicin—ovarian cancer	0.00059	0.00126	CcSEcCtD
Misoprostol—Dysuria—Doxorubicin—ovarian cancer	0.000589	0.00126	CcSEcCtD
Misoprostol—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000586	0.00125	CcSEcCtD
Misoprostol—Fatigue—Paclitaxel—ovarian cancer	0.000584	0.00125	CcSEcCtD
Misoprostol—Constipation—Paclitaxel—ovarian cancer	0.000579	0.00124	CcSEcCtD
Misoprostol—Pain—Paclitaxel—ovarian cancer	0.000579	0.00124	CcSEcCtD
Misoprostol—Haematuria—Epirubicin—ovarian cancer	0.000579	0.00124	CcSEcCtD
Misoprostol—Confusional state—Docetaxel—ovarian cancer	0.000579	0.00124	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—DOK1—ovarian cancer	0.000574	0.00295	CbGpPWpGaD
Misoprostol—Oedema—Docetaxel—ovarian cancer	0.000574	0.00123	CcSEcCtD
Misoprostol—Anaphylactic shock—Docetaxel—ovarian cancer	0.000574	0.00123	CcSEcCtD
Misoprostol—Epistaxis—Epirubicin—ovarian cancer	0.000573	0.00122	CcSEcCtD
Misoprostol—Infection—Docetaxel—ovarian cancer	0.00057	0.00122	CcSEcCtD
Misoprostol—Pneumonia—Doxorubicin—ovarian cancer	0.000565	0.00121	CcSEcCtD
Misoprostol—Shock—Docetaxel—ovarian cancer	0.000565	0.00121	CcSEcCtD
Misoprostol—Thrombocytopenia—Docetaxel—ovarian cancer	0.000562	0.0012	CcSEcCtD
Misoprostol—Drowsiness—Doxorubicin—ovarian cancer	0.000562	0.0012	CcSEcCtD
Misoprostol—Feeling abnormal—Paclitaxel—ovarian cancer	0.000558	0.00119	CcSEcCtD
Misoprostol—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000554	0.00118	CcSEcCtD
Misoprostol—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000551	0.00118	CcSEcCtD
Misoprostol—Urinary tract infection—Doxorubicin—ovarian cancer	0.000546	0.00117	CcSEcCtD
Misoprostol—Conjunctivitis—Doxorubicin—ovarian cancer	0.000546	0.00117	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—PPP1CC—ovarian cancer	0.00054	0.00277	CbGpPWpGaD
Misoprostol—Hypotension—Docetaxel—ovarian cancer	0.000536	0.00115	CcSEcCtD
Misoprostol—Haematuria—Doxorubicin—ovarian cancer	0.000536	0.00114	CcSEcCtD
Misoprostol—Abdominal pain—Paclitaxel—ovarian cancer	0.000535	0.00114	CcSEcCtD
Misoprostol—Body temperature increased—Paclitaxel—ovarian cancer	0.000535	0.00114	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—DOK1—ovarian cancer	0.00053	0.00272	CbGpPWpGaD
Misoprostol—Epistaxis—Doxorubicin—ovarian cancer	0.00053	0.00113	CcSEcCtD
Misoprostol—Visual impairment—Epirubicin—ovarian cancer	0.000525	0.00112	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000523	0.00112	CcSEcCtD
Misoprostol—Dyspnoea—Docetaxel—ovarian cancer	0.000512	0.00109	CcSEcCtD
Misoprostol—Somnolence—Docetaxel—ovarian cancer	0.00051	0.00109	CcSEcCtD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	0.000509	0.00262	CbGpPWpGaD
Misoprostol—Tinnitus—Epirubicin—ovarian cancer	0.000508	0.00109	CcSEcCtD
Misoprostol—Dyspepsia—Docetaxel—ovarian cancer	0.000505	0.00108	CcSEcCtD
Misoprostol—Hypersensitivity—Paclitaxel—ovarian cancer	0.000499	0.00107	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—HDAC6—ovarian cancer	0.000498	0.00256	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PPP1CC—ovarian cancer	0.000498	0.00256	CbGpPWpGaD
Misoprostol—Fatigue—Docetaxel—ovarian cancer	0.000495	0.00106	CcSEcCtD
Misoprostol—Immune system disorder—Epirubicin—ovarian cancer	0.000492	0.00105	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—PPP2R1A—ovarian cancer	0.000492	0.00253	CbGpPWpGaD
Misoprostol—Pain—Docetaxel—ovarian cancer	0.000491	0.00105	CcSEcCtD
Misoprostol—Constipation—Docetaxel—ovarian cancer	0.000491	0.00105	CcSEcCtD
Misoprostol—Chills—Epirubicin—ovarian cancer	0.000489	0.00104	CcSEcCtD
Misoprostol—Arrhythmia—Epirubicin—ovarian cancer	0.000487	0.00104	CcSEcCtD
Misoprostol—Visual impairment—Doxorubicin—ovarian cancer	0.000486	0.00104	CcSEcCtD
Misoprostol—Asthenia—Paclitaxel—ovarian cancer	0.000486	0.00104	CcSEcCtD
Misoprostol—Alopecia—Epirubicin—ovarian cancer	0.000482	0.00103	CcSEcCtD
Misoprostol—Feeling abnormal—Docetaxel—ovarian cancer	0.000473	0.00101	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—CXCL8—ovarian cancer	0.000472	0.00243	CbGpPWpGaD
Misoprostol—Tinnitus—Doxorubicin—ovarian cancer	0.00047	0.001	CcSEcCtD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	0.00047	0.00241	CbGpPWpGaD
Misoprostol—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000469	0.001	CcSEcCtD
Misoprostol—Flatulence—Epirubicin—ovarian cancer	0.000468	0.000999	CcSEcCtD
Misoprostol—Diarrhoea—Paclitaxel—ovarian cancer	0.000463	0.00099	CcSEcCtD
Misoprostol—Back pain—Epirubicin—ovarian cancer	0.000459	0.000981	CcSEcCtD
Misoprostol—Muscle spasms—Epirubicin—ovarian cancer	0.000456	0.000975	CcSEcCtD
Misoprostol—Immune system disorder—Doxorubicin—ovarian cancer	0.000456	0.000973	CcSEcCtD
Misoprostol—Body temperature increased—Docetaxel—ovarian cancer	0.000454	0.00097	CcSEcCtD
Misoprostol—Abdominal pain—Docetaxel—ovarian cancer	0.000454	0.00097	CcSEcCtD
Misoprostol—Chills—Doxorubicin—ovarian cancer	0.000453	0.000967	CcSEcCtD
Misoprostol—Arrhythmia—Doxorubicin—ovarian cancer	0.000451	0.000963	CcSEcCtD
Misoprostol—Dizziness—Paclitaxel—ovarian cancer	0.000448	0.000957	CcSEcCtD
Misoprostol—Alopecia—Doxorubicin—ovarian cancer	0.000446	0.000952	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—YAP1—ovarian cancer	0.000441	0.00227	CbGpPWpGaD
Misoprostol—Anaemia—Epirubicin—ovarian cancer	0.000439	0.000937	CcSEcCtD
Misoprostol—Flatulence—Doxorubicin—ovarian cancer	0.000433	0.000924	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—XIAP—ovarian cancer	0.000432	0.00222	CbGpPWpGaD
Misoprostol—Vomiting—Paclitaxel—ovarian cancer	0.000431	0.00092	CcSEcCtD
Misoprostol—Rash—Paclitaxel—ovarian cancer	0.000427	0.000912	CcSEcCtD
Misoprostol—Dermatitis—Paclitaxel—ovarian cancer	0.000427	0.000912	CcSEcCtD
Misoprostol—Syncope—Epirubicin—ovarian cancer	0.000426	0.000909	CcSEcCtD
Misoprostol—Back pain—Doxorubicin—ovarian cancer	0.000425	0.000907	CcSEcCtD
Misoprostol—Headache—Paclitaxel—ovarian cancer	0.000424	0.000907	CcSEcCtD
Misoprostol—Hypersensitivity—Docetaxel—ovarian cancer	0.000423	0.000904	CcSEcCtD
Misoprostol—Muscle spasms—Doxorubicin—ovarian cancer	0.000422	0.000902	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—SMARCA4—ovarian cancer	0.000421	0.00216	CbGpPWpGaD
Misoprostol—Loss of consciousness—Epirubicin—ovarian cancer	0.000417	0.000891	CcSEcCtD
Misoprostol—Asthenia—Docetaxel—ovarian cancer	0.000412	0.00088	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—EREG—ovarian cancer	0.000411	0.00211	CbGpPWpGaD
Misoprostol—Hypertension—Epirubicin—ovarian cancer	0.00041	0.000875	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—HDAC6—ovarian cancer	0.000409	0.0021	CbGpPWpGaD
Misoprostol—Anaemia—Doxorubicin—ovarian cancer	0.000406	0.000867	CcSEcCtD
Misoprostol—Arthralgia—Epirubicin—ovarian cancer	0.000404	0.000863	CcSEcCtD
Misoprostol—Chest pain—Epirubicin—ovarian cancer	0.000404	0.000863	CcSEcCtD
Misoprostol—Myalgia—Epirubicin—ovarian cancer	0.000404	0.000863	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—PPP2R1A—ovarian cancer	0.000404	0.00207	CbGpPWpGaD
Misoprostol—Anxiety—Epirubicin—ovarian cancer	0.000403	0.00086	CcSEcCtD
Misoprostol—Nausea—Paclitaxel—ovarian cancer	0.000402	0.00086	CcSEcCtD
Misoprostol—Syncope—Doxorubicin—ovarian cancer	0.000394	0.000841	CcSEcCtD
Misoprostol—Diarrhoea—Docetaxel—ovarian cancer	0.000393	0.000839	CcSEcCtD
Misoprostol—Confusional state—Epirubicin—ovarian cancer	0.00039	0.000834	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—CXCL8—ovarian cancer	0.000388	0.00199	CbGpPWpGaD
Misoprostol—Oedema—Epirubicin—ovarian cancer	0.000387	0.000827	CcSEcCtD
Misoprostol—Anaphylactic shock—Epirubicin—ovarian cancer	0.000387	0.000827	CcSEcCtD
Misoprostol—Loss of consciousness—Doxorubicin—ovarian cancer	0.000386	0.000824	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—PGR—ovarian cancer	0.000385	0.00198	CbGpPWpGaD
Misoprostol—Infection—Epirubicin—ovarian cancer	0.000385	0.000822	CcSEcCtD
Misoprostol—Shock—Epirubicin—ovarian cancer	0.000381	0.000814	CcSEcCtD
Misoprostol—Dizziness—Docetaxel—ovarian cancer	0.00038	0.000811	CcSEcCtD
Misoprostol—Thrombocytopenia—Epirubicin—ovarian cancer	0.000379	0.00081	CcSEcCtD
Misoprostol—Hypertension—Doxorubicin—ovarian cancer	0.000379	0.00081	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—HDAC6—ovarian cancer	0.000378	0.00194	CbGpPWpGaD
Misoprostol—Hyperhidrosis—Epirubicin—ovarian cancer	0.000374	0.0008	CcSEcCtD
Misoprostol—Myalgia—Doxorubicin—ovarian cancer	0.000374	0.000799	CcSEcCtD
Misoprostol—Chest pain—Doxorubicin—ovarian cancer	0.000374	0.000799	CcSEcCtD
Misoprostol—Arthralgia—Doxorubicin—ovarian cancer	0.000374	0.000799	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—PPP2R1A—ovarian cancer	0.000373	0.00191	CbGpPWpGaD
Misoprostol—Anxiety—Doxorubicin—ovarian cancer	0.000372	0.000796	CcSEcCtD
Misoprostol—Vomiting—Docetaxel—ovarian cancer	0.000365	0.00078	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000362	0.00186	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—YAP1—ovarian cancer	0.000362	0.00186	CbGpPWpGaD
Misoprostol—Rash—Docetaxel—ovarian cancer	0.000362	0.000773	CcSEcCtD
Misoprostol—Hypotension—Epirubicin—ovarian cancer	0.000362	0.000773	CcSEcCtD
Misoprostol—Dermatitis—Docetaxel—ovarian cancer	0.000362	0.000773	CcSEcCtD
Misoprostol—Confusional state—Doxorubicin—ovarian cancer	0.000361	0.000772	CcSEcCtD
Misoprostol—Headache—Docetaxel—ovarian cancer	0.00036	0.000768	CcSEcCtD
Misoprostol—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000358	0.000766	CcSEcCtD
Misoprostol—Oedema—Doxorubicin—ovarian cancer	0.000358	0.000766	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—PARP1—ovarian cancer	0.000358	0.00184	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CXCL8—ovarian cancer	0.000358	0.00184	CbGpPWpGaD
Misoprostol—Infection—Doxorubicin—ovarian cancer	0.000356	0.000761	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—XIAP—ovarian cancer	0.000355	0.00182	CbGpPWpGaD
Misoprostol—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000353	0.000754	CcSEcCtD
Misoprostol—Shock—Doxorubicin—ovarian cancer	0.000353	0.000753	CcSEcCtD
Misoprostol—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000351	0.00075	CcSEcCtD
Misoprostol—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000346	0.00074	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—SMARCA4—ovarian cancer	0.000346	0.00178	CbGpPWpGaD
Misoprostol—Dyspnoea—Epirubicin—ovarian cancer	0.000345	0.000738	CcSEcCtD
Misoprostol—Somnolence—Epirubicin—ovarian cancer	0.000344	0.000736	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—IL6ST—ovarian cancer	0.000342	0.00176	CbGpPWpGaD
Misoprostol—Nausea—Docetaxel—ovarian cancer	0.000341	0.000729	CcSEcCtD
Misoprostol—Dyspepsia—Epirubicin—ovarian cancer	0.000341	0.000728	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—EREG—ovarian cancer	0.000337	0.00173	CbGpPWpGaD
Misoprostol—Hypotension—Doxorubicin—ovarian cancer	0.000335	0.000715	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—YAP1—ovarian cancer	0.000334	0.00172	CbGpPWpGaD
Misoprostol—Fatigue—Epirubicin—ovarian cancer	0.000334	0.000713	CcSEcCtD
Misoprostol—Constipation—Epirubicin—ovarian cancer	0.000331	0.000708	CcSEcCtD
Misoprostol—Pain—Epirubicin—ovarian cancer	0.000331	0.000708	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—PIK3CG—ovarian cancer	0.000329	0.00169	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—XIAP—ovarian cancer	0.000327	0.00168	CbGpPWpGaD
Misoprostol—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000326	0.000697	CcSEcCtD
Misoprostol—Dyspnoea—Doxorubicin—ovarian cancer	0.000319	0.000683	CcSEcCtD
Misoprostol—Feeling abnormal—Epirubicin—ovarian cancer	0.000319	0.000682	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—SMARCA4—ovarian cancer	0.000319	0.00164	CbGpPWpGaD
Misoprostol—Somnolence—Doxorubicin—ovarian cancer	0.000319	0.000681	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000319	0.00164	CbGpPWpGaD
Misoprostol—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000317	0.000677	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—PGR—ovarian cancer	0.000316	0.00162	CbGpPWpGaD
Misoprostol—Dyspepsia—Doxorubicin—ovarian cancer	0.000315	0.000674	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—EREG—ovarian cancer	0.000311	0.0016	CbGpPWpGaD
Misoprostol—Fatigue—Doxorubicin—ovarian cancer	0.000309	0.00066	CcSEcCtD
Misoprostol—Constipation—Doxorubicin—ovarian cancer	0.000306	0.000655	CcSEcCtD
Misoprostol—Pain—Doxorubicin—ovarian cancer	0.000306	0.000655	CcSEcCtD
Misoprostol—Abdominal pain—Epirubicin—ovarian cancer	0.000306	0.000654	CcSEcCtD
Misoprostol—Body temperature increased—Epirubicin—ovarian cancer	0.000306	0.000654	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000298	0.00153	CbGpPWpGaD
Misoprostol—Feeling abnormal—Doxorubicin—ovarian cancer	0.000295	0.000631	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—PARP1—ovarian cancer	0.000294	0.00151	CbGpPWpGaD
Misoprostol—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000293	0.000626	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—PGR—ovarian cancer	0.000292	0.0015	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PPP2R1A—ovarian cancer	0.00029	0.00149	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—PIK3CD—ovarian cancer	0.000289	0.00149	CbGpPWpGaD
Misoprostol—Hypersensitivity—Epirubicin—ovarian cancer	0.000285	0.00061	CcSEcCtD
Misoprostol—Abdominal pain—Doxorubicin—ovarian cancer	0.000283	0.000605	CcSEcCtD
Misoprostol—Body temperature increased—Doxorubicin—ovarian cancer	0.000283	0.000605	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—IL6ST—ovarian cancer	0.000281	0.00144	CbGpPWpGaD
Misoprostol—Asthenia—Epirubicin—ovarian cancer	0.000278	0.000594	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000278	0.00143	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000275	0.00141	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PARP1—ovarian cancer	0.000271	0.00139	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—PIK3CG—ovarian cancer	0.00027	0.00139	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—CXCL8—ovarian cancer	0.000267	0.00137	CbGpPWpGaD
Misoprostol—Diarrhoea—Epirubicin—ovarian cancer	0.000265	0.000566	CcSEcCtD
Misoprostol—Hypersensitivity—Doxorubicin—ovarian cancer	0.000264	0.000564	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000262	0.00134	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—IL6ST—ovarian cancer	0.00026	0.00133	CbGpPWpGaD
Misoprostol—Asthenia—Doxorubicin—ovarian cancer	0.000257	0.000549	CcSEcCtD
Misoprostol—Dizziness—Epirubicin—ovarian cancer	0.000256	0.000547	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—IL2—ovarian cancer	0.000255	0.00131	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—PIK3CB—ovarian cancer	0.000252	0.0013	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PIK3CG—ovarian cancer	0.000249	0.00128	CbGpPWpGaD
Misoprostol—Vomiting—Epirubicin—ovarian cancer	0.000246	0.000526	CcSEcCtD
Misoprostol—Diarrhoea—Doxorubicin—ovarian cancer	0.000245	0.000524	CcSEcCtD
Misoprostol—Rash—Epirubicin—ovarian cancer	0.000244	0.000522	CcSEcCtD
Misoprostol—Dermatitis—Epirubicin—ovarian cancer	0.000244	0.000521	CcSEcCtD
Misoprostol—Headache—Epirubicin—ovarian cancer	0.000243	0.000518	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—CXCL8—ovarian cancer	0.000242	0.00124	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000241	0.00124	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PPP2R1A—ovarian cancer	0.000238	0.00123	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—PIK3CD—ovarian cancer	0.000238	0.00122	CbGpPWpGaD
Misoprostol—Dizziness—Doxorubicin—ovarian cancer	0.000237	0.000506	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—IL2—ovarian cancer	0.000232	0.00119	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TERT—ovarian cancer	0.000231	0.00119	CbGpPWpGaD
Misoprostol—Nausea—Epirubicin—ovarian cancer	0.00023	0.000491	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000228	0.00117	CbGpPWpGaD
Misoprostol—Vomiting—Doxorubicin—ovarian cancer	0.000228	0.000487	CcSEcCtD
Misoprostol—Rash—Doxorubicin—ovarian cancer	0.000226	0.000483	CcSEcCtD
Misoprostol—Dermatitis—Doxorubicin—ovarian cancer	0.000226	0.000482	CcSEcCtD
Misoprostol—Headache—Doxorubicin—ovarian cancer	0.000224	0.00048	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—PPP2R1A—ovarian cancer	0.00022	0.00113	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PIK3CD—ovarian cancer	0.000219	0.00113	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—CXCL8—ovarian cancer	0.000219	0.00113	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CAV1—ovarian cancer	0.000213	0.0011	CbGpPWpGaD
Misoprostol—Nausea—Doxorubicin—ovarian cancer	0.000213	0.000455	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—PIK3CB—ovarian cancer	0.00021	0.00108	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—IL2—ovarian cancer	0.000209	0.00108	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—PIK3CB—ovarian cancer	0.000207	0.00106	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ESR1—ovarian cancer	0.000206	0.00106	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IL6ST—ovarian cancer	0.000202	0.00104	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—CXCL8—ovarian cancer	0.000202	0.00104	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CXCL8—ovarian cancer	0.000199	0.00102	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PIK3CG—ovarian cancer	0.000194	0.000999	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—APC—ovarian cancer	0.000194	0.000999	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—NRAS—ovarian cancer	0.000194	0.000999	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—IL2—ovarian cancer	0.000193	0.000993	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PIK3CB—ovarian cancer	0.000191	0.000982	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—IL2—ovarian cancer	0.00019	0.000977	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TERT—ovarian cancer	0.000189	0.000973	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—MAPK3—ovarian cancer	0.000186	0.000956	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CXCL8—ovarian cancer	0.000184	0.000943	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—MAPK1—ovarian cancer	0.000177	0.00091	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—EGFR—ovarian cancer	0.000177	0.00091	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—IL2—ovarian cancer	0.000175	0.000902	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CAV1—ovarian cancer	0.000175	0.0009	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TERT—ovarian cancer	0.000175	0.000898	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PIK3CD—ovarian cancer	0.000171	0.000878	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—PIK3CA—ovarian cancer	0.000169	0.00087	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ESR1—ovarian cancer	0.000169	0.000868	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—KRAS—ovarian cancer	0.000167	0.00086	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IL6ST—ovarian cancer	0.000166	0.000854	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CAV1—ovarian cancer	0.000162	0.000831	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PIK3CG—ovarian cancer	0.00016	0.00082	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—APC—ovarian cancer	0.00016	0.00082	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—NRAS—ovarian cancer	0.00016	0.00082	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ESR1—ovarian cancer	0.000156	0.000801	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—PIK3CA—ovarian cancer	0.000154	0.00079	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IL6ST—ovarian cancer	0.000153	0.000788	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—MAPK3—ovarian cancer	0.000153	0.000785	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ERBB2—ovarian cancer	0.000151	0.000775	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PIK3CB—ovarian cancer	0.000149	0.000765	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MTOR—ovarian cancer	0.000149	0.000765	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—APC—ovarian cancer	0.000147	0.000757	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PIK3CG—ovarian cancer	0.000147	0.000757	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—NRAS—ovarian cancer	0.000147	0.000757	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—MAPK1—ovarian cancer	0.000145	0.000747	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—EGFR—ovarian cancer	0.000145	0.000747	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CXCL8—ovarian cancer	0.000143	0.000735	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—HRAS—ovarian cancer	0.000142	0.000731	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—MAPK3—ovarian cancer	0.000141	0.000725	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PIK3CD—ovarian cancer	0.00014	0.000721	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CDKN1B—ovarian cancer	0.00014	0.000718	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—PIK3CA—ovarian cancer	0.000139	0.000714	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—AKT1—ovarian cancer	0.000138	0.00071	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—KRAS—ovarian cancer	0.000137	0.000706	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CASP3—ovarian cancer	0.000137	0.000704	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IL2—ovarian cancer	0.000137	0.000703	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—IL6—ovarian cancer	0.000136	0.000699	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—MAPK1—ovarian cancer	0.000134	0.00069	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—EGFR—ovarian cancer	0.000134	0.00069	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CCND1—ovarian cancer	0.000133	0.000685	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CTNNB1—ovarian cancer	0.000132	0.000678	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PIK3CD—ovarian cancer	0.000129	0.000665	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MMP9—ovarian cancer	0.000129	0.000665	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PTEN—ovarian cancer	0.000129	0.000661	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—PIK3CA—ovarian cancer	0.000128	0.000659	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—KRAS—ovarian cancer	0.000127	0.000651	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—PIK3CA—ovarian cancer	0.000126	0.000648	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—AKT1—ovarian cancer	0.000126	0.000645	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ERBB2—ovarian cancer	0.000124	0.000637	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MTOR—ovarian cancer	0.000122	0.000628	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PIK3CB—ovarian cancer	0.000122	0.000628	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CXCL8—ovarian cancer	0.000118	0.000604	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—HRAS—ovarian cancer	0.000117	0.0006	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PIK3CA—ovarian cancer	0.000116	0.000598	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—VEGFA—ovarian cancer	0.000116	0.000597	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—STAT3—ovarian cancer	0.000115	0.000591	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—NRAS—ovarian cancer	0.000115	0.00059	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CDKN1B—ovarian cancer	0.000115	0.00059	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ERBB2—ovarian cancer	0.000114	0.000588	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—AKT1—ovarian cancer	0.000114	0.000583	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PIK3CB—ovarian cancer	0.000113	0.00058	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MTOR—ovarian cancer	0.000113	0.00058	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CASP3—ovarian cancer	0.000112	0.000578	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IL2—ovarian cancer	0.000112	0.000577	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—IL6—ovarian cancer	0.000112	0.000574	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MAPK3—ovarian cancer	0.00011	0.000565	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CCND1—ovarian cancer	0.000109	0.000563	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CXCL8—ovarian cancer	0.000108	0.000557	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CTNNB1—ovarian cancer	0.000108	0.000557	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—HRAS—ovarian cancer	0.000108	0.000554	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MYC—ovarian cancer	0.000107	0.00055	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MMP9—ovarian cancer	0.000106	0.000546	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CDKN1B—ovarian cancer	0.000106	0.000544	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PTEN—ovarian cancer	0.000106	0.000543	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—AKT1—ovarian cancer	0.000105	0.000538	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MAPK1—ovarian cancer	0.000105	0.000538	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—EGFR—ovarian cancer	0.000105	0.000537	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CASP3—ovarian cancer	0.000104	0.000533	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IL2—ovarian cancer	0.000104	0.000533	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—IL6—ovarian cancer	0.000103	0.00053	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—AKT1—ovarian cancer	0.000103	0.00053	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CCND1—ovarian cancer	0.000101	0.000519	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CTNNB1—ovarian cancer	0.0001	0.000514	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—KRAS—ovarian cancer	9.88e-05	0.000508	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MMP9—ovarian cancer	9.81e-05	0.000504	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PTEN—ovarian cancer	9.75e-05	0.000501	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—VEGFA—ovarian cancer	9.55e-05	0.00049	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—AKT1—ovarian cancer	9.51e-05	0.000489	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—STAT3—ovarian cancer	9.45e-05	0.000486	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—NRAS—ovarian cancer	9.43e-05	0.000484	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PIK3CA—ovarian cancer	9.08e-05	0.000466	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MAPK3—ovarian cancer	9.03e-05	0.000464	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—VEGFA—ovarian cancer	8.81e-05	0.000453	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TP53—ovarian cancer	8.78e-05	0.000451	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MYC—ovarian cancer	8.78e-05	0.000451	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—STAT3—ovarian cancer	8.72e-05	0.000448	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—NRAS—ovarian cancer	8.7e-05	0.000447	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MAPK1—ovarian cancer	8.59e-05	0.000441	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—EGFR—ovarian cancer	8.59e-05	0.000441	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—HRAS—ovarian cancer	8.4e-05	0.000432	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MAPK3—ovarian cancer	8.33e-05	0.000428	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—KRAS—ovarian cancer	8.11e-05	0.000417	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MYC—ovarian cancer	8.1e-05	0.000416	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IL6—ovarian cancer	8.04e-05	0.000413	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MAPK1—ovarian cancer	7.93e-05	0.000407	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—EGFR—ovarian cancer	7.93e-05	0.000407	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—KRAS—ovarian cancer	7.49e-05	0.000385	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PIK3CA—ovarian cancer	7.46e-05	0.000383	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—AKT1—ovarian cancer	7.42e-05	0.000381	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TP53—ovarian cancer	7.21e-05	0.000371	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—HRAS—ovarian cancer	6.9e-05	0.000354	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PIK3CA—ovarian cancer	6.88e-05	0.000354	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TP53—ovarian cancer	6.66e-05	0.000342	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IL6—ovarian cancer	6.6e-05	0.000339	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HRAS—ovarian cancer	6.37e-05	0.000327	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IL6—ovarian cancer	6.09e-05	0.000313	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—AKT1—ovarian cancer	6.09e-05	0.000313	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—AKT1—ovarian cancer	5.62e-05	0.000289	CbGpPWpGaD
